/Investor DB

SV Life Sciences — 2011 Investments

2 investments dated 2011 · listed companies and verified rows first · show all

CardioFocuscardiofocus.comin𝕏Feb 2011 · $30.6M

CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.

BiotechHealthtechMedical DevicesMarlborough, US

Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in

Co-investorsBioBritSaints CapitalSV Health InvestorsAccuitive Medical VenturesOxford Bioscience Partners

PanOpticapanopticapharma.comJan 2011 · $30M

BiotechMt. Arlington, US

Paul Chaney(Executive Officer, Director)

BoardAbbie Celniker(Director)inDavid Guyer(Director)Bruce Peacock(Director)Kevin Starr(Director)inLutz Giebel(Director)

Co-investorsAstellas Venture Management LLCAgent CapitalSV Health InvestorsThird Rock Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.